Author

Ken-ichi Tabata

Observed names: K Tabata, K. Tabata, Ken-Ichi Tabata, Ken‐Ichi Tabata

Institution: Kitasato Institute Hospital

Observed institutions: Michael E. DeBakey VA Medical Center, The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Kitasato University Hospital, Kitasato Institute Hospital, Kitasato University

ORCID: 0000-0001-7925-051X

Observed ORCID: 0000-0001-7925-051X

OpenAlex ID: A5113549240

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

2019 · Emmanuel S. Antonarakis, Josep M. Piulats, et al. · Journal of Clinical Oncology · 772

Tumor Cell–Secreted Caveolin-1 Has Proangiogenic Activities in Prostate Cancer

2008 · Salahaldin A. Tahir, Guang Yang, et al. · Cancer Research · 82

Caveolin-1 Promotes Autoregulatory, Akt-Mediated Induction of Cancer-Promoting Growth Factors in Prostate Cancer Cells

2009 · Likun Li, Chengzhen Ren, et al. · Molecular Cancer Research · 44

PDF

Functional Analysis of Secreted Caveolin-1 in Mouse Models of Prostate Cancer Progression

2009 · Masami Watanabe, Guang Yang, et al. · Molecular Cancer Research · 39

GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy

2011 · Guru Sonpavde, Timothy C. Thompson, et al. · Clinical Cancer Research · 33

Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer

2006 · K Naruishi, T L Timme, et al. · Cancer Gene Therapy · 25

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer

2006 · T Fujita, T L Timme, et al. · Gene Therapy · 18

Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells

2013 · R. Takahashi, H. Amano, et al. · Biomedicine & Pharmacotherapy · 17

Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model

2011 · K Tabata, S Kurosaka, et al. · Gene Therapy · 11

Expanding the Therapeutic Index of Radiation Therapy by Combining In Situ Gene Therapy in the Treatment of Prostate Cancer

2006 · Michael T. Tetzlaff, Bin S. Teh, et al. · Technology in Cancer Research & Treatment · 11

Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer

2008 · K Tabata, M Watanabe, et al. · Prostate Cancer and Prostatic Diseases · 10

Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer

2020 · Nobuyuki Yanagisawa, Takefumi Satoh, et al. · Asian journal of urology · 8

PDF

Defining Favorable Prognosis in Bone Metastatic Hormone‐Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors

2026 · Dai Koguchi, Hideyasu Tsumura, et al. · The Prostate · 3

Current status and issues regarding genetic medicine after cancer gene panel testing in Japanese patients with metastatic prostate cancer

2025 · Hideyasu Tsumura, Dai Koguchi, et al. · Molecular and Clinical Oncology · 2

PDF

Local and Distant Effects of Caveolin-1 on Prostate Cancer Progression

2011 · T. C. Thompson, S. A. Tahir, et al. · Springer eBooks · 1

601 a Phase I Study of Personalized Peptide Vaccination for Advanced Urothelial Carcinoma Patients Who Failed Treatment With Methotrexate, Vinblastine, Adriamycin and Cisplatin

2011 · K. Matsumoto, M. Noguchi, et al. · European Urology Supplements · 1

864 Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy

2012 · M. Ikeda, K. Matsumoto, et al. · European Urology Supplements

925 the Combined Investigation of Molecular Proteins Predicts Cancer-specific Survival in Patients With High-grade Non-muscle Invasive Bladder Cancer

2010 · K. Matsumoto, Y. Satoh, et al. · European Urology Supplements

Works count: 18

Citation count: 1,077

H-index: 10

I10-index: 11